MedPath

Comparison the effect of L-carnitine versus placebo on control of Attention deficit-hyper activity disorder symptoms

Not Applicable
Conditions
Attention deficit-hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT2013090914598N1
Lead Sponsor
Vice chancellor for Research Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

Age 6-16; Diagnosis of ADHD for the first time
Exclusion criteria : IQ<70 ; Having other chronic medical illnesses; Be under other medications; Any serious or sever complication during study; Refusal of child or parent to continue the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Attention, Impulsivity & Behavioral indecies. Timepoint: At the begining,3 weeks later & 6 weeks later. Method of measurement: Conner's parents questionaire.
Secondary Outcome Measures
NameTimeMethod
Child's general function. Timepoint: At the begining of study , 3 weeks later , 6 weeks later. Method of measurement: CGAS questionare.;Drug complication. Timepoint: 3 weeks after begining of the study & 6 weeks later. Method of measurement: Rachell & klein Side effects Form.
© Copyright 2025. All Rights Reserved by MedPath